Selinexor in Combination With MTX+Ritu to Treat R/R CNSL

Clinical trial NCT05698147 · RECRUITING

Trial details

NCT number: NCT05698147
Sponsor: Tong Chen, MD
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Central Nervous System Lymphoma

Start date: 2023-08-03
Primary completion: 2026-06-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.